UK becomes first country to license 3 parent babies

Published On 2016-12-16 03:57 GMT   |   Update On 2016-12-16 03:57 GMT
Advertisement
London: Britain became the first country to formally licence an in-vitro fertilisation (IVF) treatment designed to create babies from three people. UK's Human Fertilisation and Embryology Authority (HFEA) gave the final go-ahead for the treatment known as mitochondrial replacement therapy (MRT), which doctors say can help prevent incurable inherited diseases. The treatment is informally called "three-parent" IVF because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a female donor.
Advertisement

MRT is designed to prevent mitochondrial diseases from being passed on by replacing the mother's defective mitochondria with those from a healthy donor. The resulting baby would have the usual 23 pairs of chromosomes from both parents, but with mitochondria from the healthy donor. The procedure also raises ethical concerns. Because the genetic manipulation affects all of the cells in the embryo, any glitches the procedure might introduce could potentially be passed down to future generations.

The decision means the first babies created by the technique in the UK could be born as early as 2017. The government's chief scientific adviser, Mark Walport, praised the decision as a "careful and considered" assessment.

The world's first "three-parent" baby was born in September this year in Mexico. agencies
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News